rs368637389
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_001164508.2(NEB):c.8125G>A(p.Val2709Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000044 in 1,613,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001164508.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.8125G>A | p.Val2709Ile | missense_variant | Exon 58 of 182 | 5 | NM_001164508.2 | ENSP00000380505.3 | ||
NEB | ENST00000427231.7 | c.8125G>A | p.Val2709Ile | missense_variant | Exon 58 of 182 | 5 | NM_001164507.2 | ENSP00000416578.2 | ||
NEB | ENST00000409198.5 | c.8125G>A | p.Val2709Ile | missense_variant | Exon 58 of 150 | 5 | ENSP00000386259.1 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152140Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000402 AC: 10AN: 249016Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135068
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461430Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727012
GnomAD4 genome AF: 0.000296 AC: 45AN: 152258Hom.: 0 Cov.: 33 AF XY: 0.000322 AC XY: 24AN XY: 74428
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
- -
Nemaline myopathy 2 Uncertain:1Benign:1
- -
- -
Inborn genetic diseases Uncertain:1
The c.8125G>A (p.V2709I) alteration is located in exon 58 (coding exon 56) of the NEB gene. This alteration results from a G to A substitution at nucleotide position 8125, causing the valine (V) at amino acid position 2709 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at